Reaction
Respiratory Gas Exchange Disorder reporting signals
As of the last recalculation, Respiratory Gas Exchange Disorder appears in 366 FAERS reports alongside 21 co-occurring drug terms. The strongest observed disproportionality signal is CICLESONIDE (PRR 121.6).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Ciclesonide | 27 | 121.6 | 121.9 |
| Fluticasone Furoate | 24 | 120.5 | 120.7 |
| Mepolizumab | 79 | 115.0 | 115.2 |
| Ipratropium Bromide | 60 | 114.2 | 114.4 |
| Tiotropium Bromide Inhalation Spray | 18 | 96.0 | 96.2 |
| Terbinafine Hydrochloride | 14 | 93.1 | 93.3 |
| Fluticasone Furoate And Vilanterol Trifenatate | 45 | 81.0 | 81.1 |
| Norepinephrine | 13 | 71.7 | 71.8 |
| Rosuvastatin Calcium | 26 | 56.4 | 56.5 |
| Nicotine Polacrilex Mini | 14 | 55.1 | 55.2 |
| Nicotine Polarilex | 14 | 55.1 | 55.2 |
| Norepinephrine Bitartrate | 13 | 53.2 | 53.3 |
| Budesonide And Formoterol Fumarate Dihydrate | 70 | 50.5 | 50.5 |
| Moxifloxacin Hydrochloride | 16 | 46.9 | 46.9 |
| Tiotropium Bromide | 80 | 42.2 | 42.3 |
| Amikacin | 11 | 37.8 | 37.8 |
| Daptomycin | 6 | 37.6 | 37.6 |
| Linezolid | 14 | 27.8 | 27.8 |
| Nicotine | 16 | 23.5 | 23.5 |
| Nicotine Polacrilex | 14 | 21.6 | 21.6 |
| Pirfenidone | 10 | 14.3 | 14.3 |